Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys

Journal of Glaucoma

Volumn 17, Issue 1, 2008, Pages 73-78

  Wang, Rong Fang ^a,b   Gagliuso, Donna J ^a   Podos, Steven M ^a  

^a NEW YORK UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aqueous humor dynamics; Calcium channel blocker; Flunarizine; Glaucoma; Intraocular pressure; Monkey

Indexed keywords

FLUNARIZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; FLUOROPHOTOMETRY; GLAUCOMA; INTRAOCULAR PRESSURE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ANIMALS; AQUEOUS HUMOR; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUNARIZINE; FLUOROPHOTOMETRY; GLAUCOMA; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; TONOMETRY, OCULAR;

EID: 40049107727     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318133a845     Document Type: Article

References (35)

1. Campana G, Bucolo C, Murari G, et al. Ocular hypotensive action of topical flunarizine in the rabbit: role of σ-1 recognition sites. J Pharmacol Exp Ther. 2002;303:1086-1094.
2. Maltese A, Bucolo C. Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma. J Ocul Pharmacol Ther. 2003;19:171-179.
3. Osborne NN, Wood JPM, Cupido A, et al. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest Vis Ophthalmol. 2002;43:1456-1464.
4. Siegner SW, Netland PA, Schroeder A, et al. Effect of calcium channel blockers alone and in combination with antiglaucoma medications on intraocular pressure in the primate eye. J Glaucoma. 2000; 9:334-339.
5. Melena J, Santafe J, Segarra J. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits. J Pharmacol Exp Ther. 1998;284:272-282.
6. Abelson MB, Gilbert M, Smith LM. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am J Ophthalmol. 1988;105:155-159.
7. Abreu MM, Kim YY, Shin DH, et al. Topical verapamil and episcleral venous pressure. Ophthalmology. 1998;105:2251-2255.
8. Goyal JK, Khilnani G, Sharma DP, et al. The hypotensive effect of verapamil eye drops on ocular hypertension. Ind J Ophthalmol. 1989;37:176-178.
9. Netland PA, Feke GT, Konno S, et al. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma. 1996;5:200-206.
10. Netland PA, Grosskreutz CL, Feke GT et al. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am J Ophthalmol. 1995;119:694-700.
11. 2+-antagonist on visual field in low-tension glaucoma. Graefe's Arch Clin Exp Ophthalmol. 1989;227:408-412.
12. Sawada A, Kitazawa Y, Yamamoto T, et al. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996;103:283-288.
13. Netland PA, Chaturvedi N, Dreyer E. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608-611.
14. Luksch A, Rainer G, Koyuncu D, et al. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89:21-25.
15. Michalk F, Michelson G, Harazny J, et al. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma. 2004;13:158-162.
16. Cellini M, Possati GL, Caramazza N, et al. The use of flunarizine in the management of low-tension glaucoma: a color Doppler study. Acta Ophthalmol Scand Suppl. 1997;224:57-58.
17. Berger R, Lehmann T, Karcher J, et al. Low dose flunarizine protects the feral brain from ischemic injury in sheep. Pediatr Res. 1998;44:277-282.
18. Edward DP, Lam T-T, Shahinfar S, et al. Amelioration of light-induced retinal degeneration by a calcium overload blocker flunarizine. Arch Ophthalmol. 1991;109:554-562.
19. Eschweiler GW, Bahr M. Flunarizine enhances rat retinal ganglion cell survival after axotomy. J Neural Sci. 1993;116:34-40.
20. Rich HW, Hollowell JP. Flunarizine protects neurons from death after axotomy or NGF deprivation. Science. 1990;248:1419-1421.
21. Zapater P, Moreno J, Horga JF. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res. 1997;772:57-62.
22. Todd PA, Benfield P. Flunarizine a reappraisal of its pharmacological properties and therapeutic use in neurological disorders. Drugs. 1989;38:481-499.
23. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Eng J Med. 1999;341:1447-1457.
24. 2+ antagonist, increases ipsilateral optic nerve head circulation in rabbits and cynomolgus monkeys. Curr Eye Res. 2004;29:67-73.
25. Kanellopoulos AJ, Erickson KA, Netland PA. Systemic calcium channel blockers and glaucoma. J Glaucoma. 1996;5:357-362.
26. Netland PA, Erickson KA. Calcium channel blockers in glaucoma management. Ophthalmol Clin N Am. 1995;8:327-334.
27. Michelson G, Warntges S, Leidig S, et al. Nimodipine plasma concentration and retinal blood flow in healthy subjects. Invest Vis Ophthalmol. 2006;47:3479-3486.
28. Tamaki Y, Araie M, Fukaya Y, et al. Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans. Invest Vis Ophthalmol Sci. 2003;44:4864-4871.
29. Yarangumeli A, Comoglu S, Koz OG, et al. Effects of betaxalol and flunarizine on visual fields and intraocular pressure in patients with migraine. Doc Ophthalmol. 2003;106:265-270.
30. Cellini M, Versura P, Zamparini E, et al. Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction. Exp Biol Med. 2006;231:1081-1084.
31. Erickson KA, Schroeder A, Netland PA. Verapamil increases outflow facility in the human eye. Exp Eye Res. 2005;61:565-567.
32. Schuman JS, Beaton MA, Erickson KA, et al. Effects of topical verapamil on intraocular pressure, aqueous flow and outflow facility in humans. Invest Ophthalmol Vis Sci (Suppl). 1994;35:1058.
33. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res. 2000;70:475-484.
34. 2+ channel blocker NS-7 on rat ganglion cells. Jpn J Ophthalmol. 2005;49:371-376.
35. Vallazza-Deschamps G, Fuchs C, Cia D. Diltiazem-induced neuroprotection in glutamate excitotoxicity and ischemic insult of retinal neurons. Doc Ophthalmol. 2005;110:25-35.